0001193125-24-088492.txt : 20240405 0001193125-24-088492.hdr.sgml : 20240405 20240405162003 ACCESSION NUMBER: 0001193125-24-088492 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240403 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 24826776 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 8-K 1 d805485d8k.htm 8-K 8-K
AGENUS INC NASDAQ false 0001098972 --12-31 0001098972 2024-04-03 2024-04-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 3, 2024

 

 

AGENUS INC.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   000-29089   06-1562417

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

3 Forbes Road

Lexington, Massachusetts 02421

(Address of Principal Executive Offices, including Zip Code)

(781) 674-4400

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report.)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, Par Value $0.01 per share   AGEN   The Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.03.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On April 4, 2024, Agenus Inc. (the “Company”) filed a Certificate of Eighth Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s issued and outstanding common stock, par value $0.01 (the “Common Stock”) at a ratio of 1-for-20 (the “Reverse Stock Split”). Pursuant to the Certificate of Amendment, the Reverse Stock Split will be effective at 12:01 a.m., Eastern Time, on April 12, 2024. The Company expects that upon the opening of trading on April 12, 2024, the Company’s Common Stock will begin trading on a post-split basis under CUSIP number 00847G 804.

As discussed below, on April 3, 2024, the Company’s stockholders approved a proposal to amend the Certificate of Incorporation in accordance with the Certificate of Amendment at a Special Meeting of Stockholders of the Company (the “Special Meeting”). The Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K.

 

Item 5.07.

Submission of Matters to a Vote of Security Holders

The Special Meeting was held on April 3, 2024. Only stockholders of record as of February 9, 2024 (the “Record Date”) were entitled to vote at the Special Meeting. As of the Record Date, there were 399,246,272 shares outstanding and entitled to vote at the Special Meeting, of which 289,661,243 shares were represented by proxy, constituting a quorum on all matters voted upon. The final voting results of the Special Meeting are as follows:

Proposal 1: Approval of the Certificate of Amendment to the Certificate of Incorporation to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio of 1-for-20.

In accordance with the results below, Proposal 1 was approved.

 

For

 

Against

 

Abstaining

 

Broker Non-Votes

230,562,224   58,628,037   470,982   0

 

Item 9.01.

Financial Statements and Exhibits

(d) Exhibits

 

Exhibit
No.

  

Description

3.1    Certificate of Eighth Amendment to the Amended and Restated Certificate of Incorporation of Agenus Inc.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AGENUS INC.

/s/ Christine Klaskin

Name:   Christine Klaskin
Title:   Vice President, Finance

Date: April 5, 2024

 

3

EX-3.1 2 d805485dex31.htm EX-3.1 EX-3.1

Exhibit 3.1

CERTIFICATE OF EIGHTH AMENDMENT TO THE

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

AGENUS INC., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:

1. The name of the corporation is Agenus Inc. (the “Corporation”). The Corporation’s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on November 10, 1999 (the “Certificate of Incorporation”). The Certificate of Incorporation was amended and restated on June 7, 2002 (the “Restated Certificate”), which was further amended on June 15, 2007 by a Certificate of Amendment (the “First Amendment”), which was further amended on January 5, 2011 by a Certificate of Ownership and Merger (the “Name Change Amendment”), which was further amended on September 30, 2011 by a Certificate of Second Amendment (the “Second Amendment”), which was further amended on June 15, 2012 by a Certificate of Third Amendment (the “Third Amendment”), which was further amended on April 24, 2014 by a Certificate of Fourth Amendment (the “Fourth Amendment”), which was further amended on June 14, 2016 by a Certificate of Fifth Amendment (the “Fifth Amendment”), which was further amended on June 21, 2019 by a Certificate of Sixth Amendment (the “Sixth Amendment”), and which was further amended on August 5, 2022 by a Certificate of Seventh Amendment (the “Seventh Amendment”) (the Restated Certificate, as amended by the First Amendment, the Name Change Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment, the Sixth Amendment and the Seventh Amendment, the “Amended Certificate”). This Certificate of Eighth Amendment (the “Eighth Amendment”) amends certain provisions of the Amended Certificate, and has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

2. The Board of Directors of the Corporation has duly adopted a resolution, pursuant to Section 242 of the General Corporation Law of the State of Delaware, setting forth the following amendment to the Amended Certificate, and declaring the Eighth Amendment to be advisable.

3. This Eighth Amendment was duly adopted by the vote of the stockholders holding the requisite number of shares of outstanding stock of the Corporation entitled to vote thereon in accordance with the provisions of Sections 216 and 242 of the General Corporation Law of the State of Delaware.

4. The Amended Certificate is hereby amended by adding the following provision to the end of Article Fourth:

As of 12:01 A.M. (Eastern Time) on April 12, 2024 (the “Second Effective Time”), each issued and outstanding share of the Corporation’s Common Stock (including each share of treasury stock, collectively, the “Pre-Second Split Stock”) shall automatically and without any action on the part of the holder thereof be reclassified as and reduced to one twentieth of a share of Common Stock (such reduction of shares designated as the “Second Reverse Stock Split”). The par value of the Corporation’s Common Stock following the Second Reverse Stock Split shall remain $0.01 per share. Each holder of a certificate or certificates of Pre-Second Split Stock shall be entitled to receive, upon surrender of such certificates to the Corporation’s transfer agent for cancellation, a new certificate or certificates for a number of shares equal to such holder’s Pre-Second Split Stock divided by twenty (20), with any fraction resulting from such division rounded down to the nearest whole number (in each case, such fraction, if any, being a “Second Fractional Share”). No Fractional Shares will be issued for Pre-Second Split Stock in connection with the Second Reverse Stock Split. Each holder of Pre-Second Split Stock at the Second Effective Time who would otherwise be entitled to a Fractional Share shall, in lieu thereof, receive a cash payment equal to x) the Second Fractional Share multiplied by y) the product of (i) the average of the high and low trading prices of the Common Stock as reported on The NASDAQ Capital Market or other principal market of the Common Stock, as applicable, during each of the ten (10) trading days immediately preceding the date of the Second Effective Time and (ii) twenty (20).”

 

1


5. This Eighth Amendment shall be effective as of April 12, 2024 in accordance with the provisions of Section 103(d) of the General Corporation Law of the State of Delaware.

6. Except as set forth in this Eighth Amendment, the Restated Certificate remains in full force and effect.

[Signature Page to Follow]

 

-2-


IN WITNESS WHEREOF, the undersigned has duly executed this Eighth Amendment in the name of and on behalf of the Corporation on this 4th day of April, 2024.

 

AGENUS INC.
By:   /s/ Garo H. Armen
Name:   Garo H. Armen
Title:   Chief Executive Officer

 

-3-

EX-101.SCH 3 agen-20240403.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 agen-20240403_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Security Exchange Name Security Exchange Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Security 12b Title Security 12b Title Trading Symbol Trading Symbol Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 agen-20240403_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information
Apr. 03, 2024
Cover [Abstract]  
Entity Registrant Name AGENUS INC
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001098972
Current Fiscal Year End Date --12-31
Document Type 8-K
Document Period End Date Apr. 03, 2024
Entity Incorporation State Country Code DE
Entity File Number 000-29089
Entity Tax Identification Number 06-1562417
Entity Address, Address Line One 3 Forbes Road
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02421
City Area Code (781)
Local Phone Number 674-4400
Security 12b Title Common Stock, Par Value $0.01 per share
Trading Symbol AGEN
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( (""A5@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " " @H58F^&;\>\ K @ $0 &1O8U!R;W!S+V-O&ULS9)- M:L,P$$:O4K2WQW::0H2C34M7+10::,E.2)-$Q/I!FF+G]I7=Q"&T!RAHHYE/ M;]Z 6A6X\A'?H@\8R6"Z&VSG$E=AS0Y$@0,D=4 K4YD3+C=W/EI)^1KW$*0Z MRCU"4U4/8)&DEB1A!!9A)C+1:L551$D^GO%:S?CP%;L)IA5@AQ8=):C+&I@8 M)X;3T+5P!8PPPFC33P'U3)RJ?V*G#K!S5]6K

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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, dei:SecurityExchangeName - d805485d8k.htm 7 agen-20240403.xsd agen-20240403_lab.xml agen-20240403_pre.xml d805485d8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d805485d8k.htm": { "nsprefix": "agen", "nsuri": "http://www.agenusbio.com/20240403", "dts": { "schema": { "local": [ "agen-20240403.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "agen-20240403_lab.xml" ] }, "presentationLink": { "local": [ "agen-20240403_pre.xml" ] }, "inline": { "local": [ "d805485d8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-04-03_to_2024-04-03", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d805485d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-04-03_to_2024-04-03", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d805485d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.agenusbio.com//20240403/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001193125-24-088492-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-088492-xbrl.zip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end XML 18 d805485d8k_htm.xml IDEA: XBRL DOCUMENT 0001098972 2024-04-03 2024-04-03 AGENUS INC NASDAQ false 0001098972 --12-31 8-K 2024-04-03 DE 000-29089 06-1562417 3 Forbes Road Lexington MA 02421 (781) 674-4400 Common Stock, Par Value $0.01 per share AGEN false false false false false